查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1579335

爱迪生氏症检测市场：按产品、检测类型、样本类型和最终用户划分 - 全球预测 2025-2030

Addison's Disease Testing Market by Offering (Consumables, Instruments & Devices, Software & Services), Test Type (Autoantibody Tests, Biochemical Tests, Imaging Tests), Sample Type, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，爱迪生氏症检测市值为2.5702亿美元，预计到2024年将达到2.6669亿美元，复合年增长率为3.91%，到2030年将达到3.3641亿美元。

爱迪生氏症检查筛检肾上腺功能不全，这是一种以肾上腺激素分泌不足为特征的疾病。这项测试非常重要，因为它有助于及时诊断和治疗爱迪生氏症，并可以预防肾上腺危像等潜在危及生命的疾病。对这些测试的需求源于该疾病的特异性症状，这些症状经常被误认为是其他疾病，使得早期检测变得困难，但至关重要。最终用途是医疗机构、研究机构和专科诊所。市场洞察表明，人们对内分泌疾病的认识不断提高、诊断技术的进步以及自体免疫疾病盛行率的上升正在推动这一增长。关键的成长要素包括快速和非侵入性检测方法等技术创新、提高患者依从性和推动需求。此外，发展中地区医疗保健支出的增加带来了新的成长途径。最近的发展表明，数位医疗的进步促进了远端医疗和远距测试的潜在机会，从而允许进入渗透不足的市场。为了利用这些机会，公司应该投资开发具有成本效益的可携式测试解决方案，并与数位健康平台合作以扩大其覆盖范围。然而，挑战仍然存在，例如严格的监管合规性、与先进测试技术相关的高成本以及低收入地区的意识有限，这可能会阻碍市场扩张。解决这些限制需要策略伙伴关係、简化监管和进行宣传活动。促进业务成长的创新研究领域包括开发与人工智慧整合的就地检验设备，用于预测诊断和个人化治疗计划。爱迪生氏症检测市场本质上受到医疗保健趋势和技术进步的影响，因此处于研发前沿并利用与高科技公司的伙伴关係可以提高您的竞争力并确保业务的可持续性。

主要市场统计
基准年[2023] 25702万美元
预测年份 [2024] 26669万美元
预测年份 [2030] 33641万美元
复合年增长率（%） 3.91%

市场动态：快速发展的爱迪生氏症检测市场的关键市场洞察

爱迪生氏症检测市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 由于与爱迪生氏症相关的临床试验和研究活动增加，推动了检测需求
    • 提供爱迪生氏症检测优惠报销政策以促进市场成长
    • 扩大新兴国家的医疗基础设施和诊断中心
    • 产业主要企业之间的协作和伙伴关係，以增强测试产品和市场覆盖范围
  • 市场限制因素
    • 监管障碍和漫长的核准流程减缓了先进测试技术的引入
    • 缺乏专门的诊断设施和训练有素的专业人员会影响测试品质和患者结果
  • 市场机会
    • 对爱迪生氏症家庭诊断试剂套件的需求不断增长
    • 支持罕见疾病研究和诊断的政府措施和资金
    • 透过扩大新兴市场的医疗基础设施来改善检测机会
  • 市场挑战
    • 爱迪生氏症诊断测试​​和治疗的费用高昂且保险范围有限
    • 缺乏标准化的测试通讯协定以及测试可用性的区域差异

波特五力：驾驭爱迪生氏症检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解爱迪生氏症检测市场的外部影响

外部宏观环境因素在塑造爱迪生氏症检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解爱迪生氏症检测市场的竞争状况

爱迪生氏症检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵爱迪生氏症检测市场供应商的绩效评估

FPNV 定位矩阵是评估爱迪生氏症检测市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了爱迪生氏症检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对爱迪生氏症检测市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 与爱迪生氏症相关的临床试验和研究活动的增加增加了对检测的需求。
      • 爱迪生氏症检测的优惠报销政策推动市场成长
      • 扩大新兴国家的医疗基础设施和诊断中心
      • 主要行业参与者之间的合作和伙伴关係增强了测试交付和市场覆盖范围
    • 抑制因素
      • 监管障碍和漫长的核准流程减缓了先进测试技术的引入
      • 缺乏专门的诊断设施和训练有素的专业人员会影响测试品质和患者结果
    • 机会
      • 对爱迪生氏症家庭诊断试剂套件的需求增加
      • 支持罕见疾病研究和诊断的政府措施和资金
      • 扩大新兴市场的医疗保健基础设施改善了检测的机会
    • 任务
      • 爱迪生氏症的诊断检查和治疗费用昂贵，而且保险范围有限。
      • 缺乏标准化的测试通讯协定以及不同地区的测试可用性不同
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章爱迪生氏症检测市场：透过提供

  • 消耗品
    • 试剂
    • 检测套组
  • 设备和装置
    • 血液分析仪
    • CT扫描仪
    • 核磁共振造影系统
  • 软体和服务

第七章爱迪生氏症检测市场（按检测类型）

  • 自体抗体测试
  • 生物化学检验
    • ACTH兴奋试验
    • 基准皮质醇测试
    • 电解质板
    • 肾素-醛固酮比值
    • 血清ACTH测试
  • 影像检查

第八章爱迪生氏症检测市场（按样本类型）

  • 验血
  • 唾液测试
  • 尿液检查

第 9 章爱迪生氏症检测市场：依最终用途分类

  • 医院/临床实验室
  • 门诊

第十章 美洲爱迪生氏症检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区爱迪生氏症检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲爱迪生氏症检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Abcam Limited
  • ARUP Laboratories
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Max Lab
  • Merck KGaA
  • Metropolis Healthcare
  • Myriad Genetics, Inc.
  • Quest Diagnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-B53D3ECDDA3A

The Addison's Disease Testing Market was valued at USD 257.02 million in 2023, expected to reach USD 266.69 million in 2024, and is projected to grow at a CAGR of 3.91%, to USD 336.41 million by 2030.

Addison's Disease Testing involves screening for adrenal insufficiency, a condition characterized by inadequate production of adrenal hormones. This testing is critical as it helps in the timely diagnosis and management of Addison's Disease, thus preventing potential life-threatening situations such as adrenal crisis. The necessity of these tests stems from the disease's non-specific symptoms, often mistaken for other ailments, making early detection challenging yet crucial. Applications primarily lie in endocrinology and diagnostic laboratories, while end-use comprises healthcare facilities, research institutes, and specialty clinics. Market insights indicate growth driven by increasing awareness of endocrine disorders, advancements in diagnostic technologies, and a rising prevalence of autoimmune diseases. Key growth factors include technological innovations such as rapid and non-invasive testing methods, which enhance patient compliance and boost demand. Moreover, increased healthcare expenditure in developing regions presents new growth avenues. Recent trends suggest a potential opportunity in telemedicine and remote testing facilitated by digital health advancements, enabling access to underpenetrated markets. To capitalize on these opportunities, businesses should invest in developing cost-effective, portable testing solutions and collaborate with digital health platforms to expand their reach. However, challenges persist, such as stringent regulatory compliances, high costs associated with advanced testing technologies, and limited awareness in low-income regions, which could hinder market expansion. Addressing these limitations requires strategic partnerships, regulatory streamlining, and awareness campaigns. Innovative research areas for business growth include developing point-of-care testing devices integrated with AI for predictive diagnostics and personalized treatment plans. As the market for Addison's Disease Testing is inherently influenced by healthcare trends and technological advancements, staying at the forefront of R&D and leveraging partnerships with tech companies can offer a competitive edge, ensuring sustained business growth and market relevance.

KEY MARKET STATISTICS
Base Year [2023] USD 257.02 million
Estimated Year [2024] USD 266.69 million
Forecast Year [2030] USD 336.41 million
CAGR (%) 3.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Addison's Disease Testing Market

The Addison's Disease Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of clinical trials and research activities on Addison's disease driving demand for testing
    • Availability of favorable reimbursement policies for Addison's disease testing boosting market growth
    • Expansion of healthcare infrastructure and diagnostic centers in emerging economies
    • Collaborations and partnerships among key industry players to enhance test offerings and market reach
  • Market Restraints
    • Regulatory hurdles and lengthy approval processes delaying the introduction of advanced testing technologies
    • Shortage of specialized diagnostic facilities and trained professionals impacting the quality of testing and patient outcomes
  • Market Opportunities
    • Rising demand for home-based diagnostic kits for Addison's disease
    • Government initiatives and funding supporting rare disease research and diagnostics
    • Expansion of healthcare infrastructure in emerging markets boosting testing accessibility
  • Market Challenges
    • High cost and limited insurance coverage for Addison's disease diagnostic tests and treatments
    • Lack of standardized testing protocols and variability in testing availability across different regions

Porter's Five Forces: A Strategic Tool for Navigating the Addison's Disease Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Addison's Disease Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Addison's Disease Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Addison's Disease Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Addison's Disease Testing Market

A detailed market share analysis in the Addison's Disease Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Addison's Disease Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Addison's Disease Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Addison's Disease Testing Market

A strategic analysis of the Addison's Disease Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Addison's Disease Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Limited, ARUP Laboratories, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Hologic, Inc., Max Lab, Merck KGaA, Metropolis Healthcare, Myriad Genetics, Inc., Quest Diagnostics, Quidel Corporation, Randox Laboratories Ltd., Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Addison's Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Consumables, Instruments & Devices, and Software & Services. The Consumables is further studied across Reagents and Test Kits. The Instruments & Devices is further studied across Blood Analyzers, CT Scanners, and MRI Machines.
  • Based on Test Type, market is studied across Autoantibody Tests, Biochemical Tests, and Imaging Tests. The Biochemical Tests is further studied across ACTH Stimulation Test, Baseline Cortisol Test, Electrolyte Panel, Renin-Aldosterone Ratio, and Serum ACTH Test.
  • Based on Sample Type, market is studied across Blood Tests, Saliva Tests, and Urine Tests.
  • Based on End-Use, market is studied across Hospital/Clinical Laboratory and Outpatient Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of clinical trials and research activities on Addison's disease driving demand for testing
      • 5.1.1.2. Availability of favorable reimbursement policies for Addison's disease testing boosting market growth
      • 5.1.1.3. Expansion of healthcare infrastructure and diagnostic centers in emerging economies
      • 5.1.1.4. Collaborations and partnerships among key industry players to enhance test offerings and market reach
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory hurdles and lengthy approval processes delaying the introduction of advanced testing technologies
      • 5.1.2.2. Shortage of specialized diagnostic facilities and trained professionals impacting the quality of testing and patient outcomes
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for home-based diagnostic kits for Addison's disease
      • 5.1.3.2. Government initiatives and funding supporting rare disease research and diagnostics
      • 5.1.3.3. Expansion of healthcare infrastructure in emerging markets boosting testing accessibility
    • 5.1.4. Challenges
      • 5.1.4.1. High cost and limited insurance coverage for Addison's disease diagnostic tests and treatments
      • 5.1.4.2. Lack of standardized testing protocols and variability in testing availability across different regions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Addison's Disease Testing Market, by Offering

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Reagents
    • 6.2.2. Test Kits
  • 6.3. Instruments & Devices
    • 6.3.1. Blood Analyzers
    • 6.3.2. CT Scanners
    • 6.3.3. MRI Machines
  • 6.4. Software & Services

7. Addison's Disease Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Autoantibody Tests
  • 7.3. Biochemical Tests
    • 7.3.1. ACTH Stimulation Test
    • 7.3.2. Baseline Cortisol Test
    • 7.3.3. Electrolyte Panel
    • 7.3.4. Renin-Aldosterone Ratio
    • 7.3.5. Serum ACTH Test
  • 7.4. Imaging Tests

8. Addison's Disease Testing Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood Tests
  • 8.3. Saliva Tests
  • 8.4. Urine Tests

9. Addison's Disease Testing Market, by End-Use

  • 9.1. Introduction
  • 9.2. Hospital/Clinical Laboratory
  • 9.3. Outpatient Clinics

10. Americas Addison's Disease Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Addison's Disease Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Addison's Disease Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam Limited
  • 3. ARUP Laboratories
  • 4. Beckman Coulter, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Danaher Corporation
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche Ltd
  • 10. Hologic, Inc.
  • 11. Max Lab
  • 12. Merck KGaA
  • 13. Metropolis Healthcare
  • 14. Myriad Genetics, Inc.
  • 15. Quest Diagnostics
  • 16. Quidel Corporation
  • 17. Randox Laboratories Ltd.
  • 18. Siemens Healthineers
  • 19. Sysmex Corporation
  • 20. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ADDISON'S DISEASE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ADDISON'S DISEASE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ADDISON'S DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ADDISON'S DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ADDISON'S DISEASE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ADDISON'S DISEASE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY MRI MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY AUTOANTIBODY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ACTH STIMULATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BASELINE CORTISOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY RENIN-ALDOSTERONE RATIO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SERUM ACTH TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITAL/CLINICAL LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY INSTRUMENTS & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 326. ADDISON'S DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 327. ADDISON'S DISEASE TESTIN